Next Steps in Research: Recommendations From PWS Experts A recent collaborative workshop hosted by the Foundation for Prader-Willi Research (FPWR) and the International Prader-Willi Syndrome Organisation (IPWSO), and led by Drs
Ceci Connolly, president and CEO of the Alliance for Community Health Plans, told Fierce Healthcare in an email that given some alarming adverse events and the steep price tag, ACHP and our member companies are focused on ensuring prescribing decisions are based on science as well as on providing patients with the best care possible. David Allen, a spokesperson for AHIP, echoed Connolly in an email to Fierce Healthcare, saying that insurers routinely review treatments for obesity, including lifestyle changes and nutrition counseling
The FDA could simply remove the peptides from Category 2, those it considers unsafe
After being ubiquitinated by E3 ubiquitin ligase, mitochondrial surface proteins are recognized by Doa1 via facilitation by Ubx2 and are subsequently recruited to an Ufd1-Npl4 heterodimer [49]
Tonya Silva Pereira, owner of Tonya Beauty, could not be reached for comment
10.1016/j.peptides.2013.12.015 32